CANINE CANCER RESEARCH ALLIANCE (EIN 823762441) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

Mari Whitaker

Phone

4254664453

Tax Period

2023-01-01 to 2023-12-31

CANINE CANCER RESEARCH ALLIANCE, founded in 2017, is a small nonprofit in the Animal-Related sector that reported $525K in total revenue in fiscal year 2023. Revenue surged 26% from the prior year, signaling strong growth momentum. The organization ran a surplus of $139K, a strong 27% operating margin.

Mission

THE MISSION OF THE CANINE CANCER ALLIANCE IS TO END DOG CANCER AS WE KNOW IT TODAY BY FUNDING AND ADVANCING RESEARCH FOR PREVENTION AND CURES. STUDIES AND CLINICAL TRIALS SUPPORTED BY THE CCA EMPHASIZE THE DEVELOPMENT OF SAFE, EFFECTIVE, AND AFFORDABLE TREATMENTS FOR DOGS WITH CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $515,661

Program Service Revenue $0

Investment Income $8,903

Other Revenue $0

TOTAL REVENUE $524,564

Expense Breakdown

Grants Paid $335,000

Salaries & Benefits $0

Fundraising Expenses $21,370

Program Expenses $357,547

Other Expenses $50,516

TOTAL EXPENSES $385,516

Year-over-Year Comparison

	2023	2022	Change
Revenue	$524,564	$415,845	+0.3%
Expenses	$385,516	$211,915	+0.8%
Net Income	$139,048	$203,930	-0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Mari Maeda Whitaker	Director, Officer	40	Officer Director	$0	$0	$0
Tai Truong	Director	0.5	Director	$0	$0	$0
Sri Kumar	Director	0.5	Director	$0	$0	$0
Sam Earp	Director	0.5	Director	$0	$0	$0
Elizabeth Zuidema	Director	0.5	Director	$0	$0	$0
James Gimlett	Director	1	Director	$0	$0	$0
Jordan Katzman	Director	10	Director	$0	$0	$0
Norman Whitaker	Director	4	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$524,564	$385,516	$516,570	$139,048
2022	$415,845	$211,915	$370,858	$203,930

CANINE CANCER RESEARCH ALLIANCE